Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-09

Clinical Trial Update: A Study to Learn About the Safety of BIIB115 Injections and How BIIB115 is Processed in the Bodies of Healthy Adult Male Volunteers and of Pediatric Participants With Spinal Muscular Atrophy Who Previously Took Onasemnogene Abeparvovec [Phase 1]

View source ↗

Summary

Phase 1 study update evaluating the safety and pharmacokinetics of BIIB115 in healthy adult volunteers and in pediatric spinal muscular atrophy patients who pre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIIB115
  • Onasemnogene abeparvovec (onasemnogene abeparvovec)

Snippet

Sponsor: Biogen | Conditions: Healthy Volunteer, Muscular Atrophy, Spinal | Phase 1 | Status: ACTIVE_NOT_RECRUITING